首页> 外文期刊>中华医学杂志(英文版) >Combined action of C-reactive protein and lipid profiles on risk of hypertension and prehypertension in Mongolian adults in Inner Mongolia, China
【24h】

Combined action of C-reactive protein and lipid profiles on risk of hypertension and prehypertension in Mongolian adults in Inner Mongolia, China

机译:C反应蛋白和脂质谱对内蒙古蒙古成年人高血压和高血压前期风险的联合作用

获取原文
获取原文并翻译 | 示例
       

摘要

Background Many studies have suggested that C-reactive protein (CRP) and blood lipids are associated with hypertension and cardiovascular disease (CVD).However,few studies discussed the combined action of CRP and blood lipids on the risk of hypertension and prehypertension.This study aimed to investigate the combined action of CRP and lipid profiles on the risk of hypertension and prehypertension in Mongolian adults from Inner Mongolia,China.Methods The systolic and diastolic blood pressure,height,weight and waist circumference were measured and factors such as smoking,alcohol intake,family history of hypertension,etc.,were investigated and CRP,low-density lipoprotein cholesterol (LDL-C),triglycerides (TG) were tested for 2 534 Mongolian adults aged ≥20 years.The subjects were divided into four subgroups,namely CRP <median and LDL-C (TG) <median subgroup,CRP <median and LDL-C (TG) >median subgroup,CRP >median and LDL-C (TG) <median subgroup and CRP >median and LDL-C (TG) >median subgroup.The ORs (95% C/s) of hypertension and prehypertension for the subgroups were calculated by univariate and multivariate analysis.Results The multivariate adjusted ORs (95%CIs) of hypertension/prehypertension were 1.389 (0.979-1.970)/1.1 51(0.865-1.531),1.666 (1.159-2.394)/1.431 (1.060-1.930),1.756 (1.242-2.484)/ 1.770 (1.321-2.372),for CRP <median and LDL-C >median subgroup,CRP >median and LDL-C <median subgroup,and CRP >median and LDL-C >median subgroup,respectively,compared with CRP <median and LDL-C <median subgroup.Similarly,the multivariate adjusted ORs (95% CIs) of hypertension/prehypertension were 2.032 (1.394-2.963)/1.442 (1.047-1.988),1.412 (0.960-2.079)/1.596 (1.166-2.184),and 2.197 (1.595-3.027)/1.730 (1.321-2.266) for CRP <median and TG >median subgroup,CRP >median and TG <median subgroup,and CRP >median and TG >median subgroup,respectively,compared with CRP <median and TG <median subgroup.The risks of hypertension and prehypertension were the highest in the CRP >median and LDL-C (TG) >median subgroup among the four subgroups.Conclusions Subjects with both CRP >median and LDL-C (TG) >median had highest risks of hypertension and prehypertension among all subjects.This study appeared to indicate that the combined action of elevated CRP and elevated LDL-C (TG) further increase the risks of hypertension and prehypertension among Mongolian population.
机译:背景许多研究表明C反应蛋白(CRP)和血脂与高血压和心血管疾病(CVD)有关。但是,很少有研究讨论CRP和血脂对高血压和高血压前期风险的联合作用。目的探讨CRP和血脂谱对内蒙古蒙古族成年人高血压和高血压前期风险的联合作用。方法测量收缩压和舒张压,身高,体重和腰围以及吸烟,饮酒等因素对2534名年龄在20岁以上的蒙古成年人进行了CRP,低密度脂蛋白胆固醇(LDL-C),甘油三酸酯(TG)检查,并对摄入量,高血压家族史等进行了调查。受试者分为四个亚组,即CRP <中位和LDL-C(TG)<中位亚组,CRP <中位和LDL-C(TG)>中位亚组,CRP>中位和LDL-C(TG)<中位亚组和CRP>中位和LDL-C (TG)>中位子通过单因素和多因素分析计算出亚组的高血压和高血压前期的OR(95%C / s)。结果高血压/高血压前期的多元调整后OR(95%CIs)为1.389(0.979-1.970)/1.1 51 (0.865-1.53​​1),1.666(1.159-2.394)/1.431(1.060-1.930),1.756(1.242-2.484)/ 1.770(1.321-2.372),用于CRP <中位数和LDL-C>中位数子组,CRP>中位数和与CRP <中位数和LDL-C <中位数亚组相比,LDL-C <中位数亚组和CRP>中位数和LDL-C>中位数亚组。同样,高血压/高血压的多因素校正ORs(95%CIs)为CRP <中值和TG>中值的2.032(1.394-2.963)/1.442(1.047-1.988),1.412(0.960-2.079)/1.596(1.166-2.184)和2.197(1.595-3.027)/1.730(1.321-2.266)亚组,CRP>中和TG <中亚组,CRP>中和TG>中亚组,分别与CRP <中和TG <中亚组相比。CRP>中a的高血压和高血压前患风险最高在这四个亚组中,LDL-C(TG)>中位亚组。结论CRP>中位和LDL-C(TG)>中位的受试者在所有受试者中患高血压和高血压的风险最高。 CRP和LDL-C(TG)升高的作用进一步增加了蒙古族人群患高血压和高血压的风险。

著录项

  • 来源
    《中华医学杂志(英文版)》 |2014年第11期|2016-2020|共5页
  • 作者单位

    Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215123, China;

    Department of Food Sanitation, Suzhou Food and Drug Administration, Suzhou, Jiangsu 215007, China;

    Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215123, China;

    Department of Neurology, Affiliated Hospital of Hebei United University,Tangshan, Hebei 063000, China;

    Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215123, China;

    Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215123, China;

    Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215123, China;

    Department of Health Care, Xiamen Maternal and Child Care Hospital, Xiamen, Fujian 361003, China;

    Department of Neurology, Affiliated Hospital of Hebei United University,Tangshan, Hebei 063000, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:59:05
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号